Helen Stevenson is Founder and CEO of Reformulary Group Inc., a healthcare company that built a proprietary evidence-based drug list, the Reformulary®, and award-winning DrugFinder™ tool that provides Canadians with valuable, comparative drug information and saves money for organization’s health benefit plans. The Company has a formidable data asset, providing innovative and valuable insights to healthcare stakeholders, and has recently launched the first-of-its-kind tool to capture real-world evidence (RWE) related to productivity – in addition to its RWE quality of life tool. 

In 2018, Helen was named by MaRS Discovery District as one of eight Canadian female founders who have a relentless pursuit of success in science and tech. Helen is the former Assistant Deputy Minister of Health and Executive Officer of Ontario Public Drug Programs. Under her leadership, the Government achieved an unprecedented $1.5 billion in savings over five years.  

Helen holds a BCom from McGill University, Montreal, and a Master of Science in Management from Boston University Brussels. She holds the ICD.D designation.

Speaking on: ROCKET PITCHES - EARLY STAGE